← Leaderboards
Nancy B. Kiviat
University Of Washington
$21,349,193
Attributed
$23,506,589
Total exposure
14
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–15$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$23,506,589 · 14
By mechanism
R01$19,124,090 · 10
P50$1,817,616 · 1
U01$1,709,313 · 1
N01$558,818 · 1
U54$296,752 · 1
Top collaborators
- Shalini L Kulasingam5 shared
- Karol Bomsztyk2 shared
Most similar at University Of Washington
Same institution · by research overlap
- Long Fu Xi$3,769,214
- Anna Wald$34,443,936
- Rachel L. Winer$10,191,453
- Michael Hoonbae Chung$4,690,025
- McKenna Claire Eastment$3,618,766
Others in their field
Top investigators on “Human Papillomavirus”
- Ronald T Mitsuyasu · University Of California Los Angeles$106,431,894
- Leonard Freedman · Leidos Biomedical Research, Inc.$53,948,093
- Kathryn M Anastos · Montefiore Medical Center (Bronx, Ny)$50,130,116
- Paula Gonzalez-Maya · Fundacion Inciensa$38,145,031
- David Heimbrook · Leidos Biomedical Research, Inc.$33,306,253
- Paul F Lambert · University Of Wisconsin Madison$31,091,618
Research focus
Human PapillomavirusHuman SubjectClinical ResearchBaseHiv InfectionsBiopsyHuman TissueTissue /Cell CultureMalignant Neoplasm Of Cervix UteriPublic Health Medicine (Field)GenesSamplingWomanOvary NeoplasmsTissue Resource /RegistryBiomedical FacilityEpigenetic ProcessEnrollmentCytologyInfectionHuman Papilloma Virus InfectionCervicalCervical Intraepithelial NeoplasiaBiomarker
Grant awards (55)
Cytology vs at home HPV screening for detection of CIN 2,3,CIS$580,766
R01 · FY2015 · CA · contact PI
Cytology vs at home HPV screening for detection of CIN 2,3,CIS$583,211
R01 · FY2014 · CA · contact PI
Cytology vs at home HPV screening for detection of CIN 2,3,CIS$576,473
R01 · FY2013 · CA · contact PI
Cytology vs at home HPV screening for detection of CIN 2,3,CIS$628,826
R01 · FY2012 · CA · contact PI
Cytology vs at home HPV screening for detection of CIN 2,3,CIS$658,028
R01 · FY2011 · CA · contact PI
Epigenetic changes predict disease course of HPV-related lesions in women 16-24$626,626
R01 · FY2010 · CA · contact PI
Chlamydia & Aberrant DNA Methylation in Cervical Cancer$446,125
R01 · FY2010 · CA · contact PI
Epigenetic changes predict disease course of HPV-related lesions in women 16-24$660,862
R01 · FY2009 · CA · contact PI
HIV Associated DNA Hypermethylation in Cervical Cancer$493,582
R01 · FY2009 · CA · contact PI
Chlamydia & Aberrant DNA Methylation in Cervical Cancer$490,342
R01 · FY2009 · CA · contact PI
Core--Specimen$531,317
P50 · FY2008 · CA · contact PI
Chlamydia & Aberrant DNA Methylation in Cervical Cancer$495,349
R01 · FY2008 · CA · contact PI
HIV Associated DNA Hypermethylation in Cervical Cancer$493,582
R01 · FY2008 · CA · contact PI
Core--Specimen$514,995
P50 · FY2007 · CA · contact PI
Chlamydia & Aberrant DNA Methylation in Cervical Cancer$505,777
R01 · FY2007 · CA · contact PI
HIV Associated DNA Hypermethylation in Cervical Cancer$486,051
R01 · FY2007 · CA · contact PI
Chlamydia & Aberrant DNA Methylation in Cervical Cancer$532,690
R01 · FY2006 · CA · contact PI
HIV Associated DNA Hypermethylation in Cervical Cancer$495,235
R01 · FY2006 · CA · contact PI
Developing New Approaches for Cervical Cancer Control$463,388
R01 · FY2006 · CA · contact PI
Core--Specimen$263,891
P50 · FY2006 · CA · contact PI
HIV Associated DNA Hypermethylation in Cervical Cancer$619,482
R01 · FY2005 · CA
Developing New Approaches for Cervical Cancer Control$574,343
R01 · FY2005 · CA
Epidemiology of HPV and p53 Mutations in NM Skin Cancer$547,725
R01 · FY2005 · CA
Core--Specimen$256,606
P50 · FY2005 · CA
Melanoma vaccines$239,528
R01 · FY2005 · CA
CONTROL OF HIV-1 BY HIV-2 ASSOCIATED IMMUNE RESPONSES$571,118
R01 · FY2004 · AI
Epidemiology of HPV and p53 Mutations in NM Skin Cancer$562,396
R01 · FY2004 · CA
Developing New Approaches for Cervical Cancer Control$559,523
R01 · FY2004 · CA
Core--Specimen$250,807
P50 · FY2004 · CA
CONTROL OF HIV-1 BY HIV-2 ASSOCIATED IMMUNE RESPONSES$560,978
R01 · FY2003 · AI
Epidemiology of HPV and p53 Mutations in NM Skin Cancer$548,433
R01 · FY2003 · CA
Developing New Approaches for Cervical Cancer Control$547,547
R01 · FY2003 · CA
BIOMAKERS DEVELOPMENT LABORATORY$446,945
U01 · FY2003 · CA
Developing New Approaches for Cervical Cancer Control$573,046
R01 · FY2002 · CA
Epidemiology of HPV and p53 Mutations in NM Skin Cancer$522,427
R01 · FY2002 · CA
CONTROL OF HIV-1 BY HIV-2 ASSOCIATED IMMUNE RESPONSES$460,683
R01 · FY2002 · AI
BIOMAKERS DEVELOPMENT LABORATORY$432,062
U01 · FY2002 · CA
CORE--SPECIMEN FACILIGY$296,752
U54 · FY2002 · CA
CORE--SPECIMEN REPOSITORY AND LABORATORY$0
P50 · FY2002 · CA
Epidemiology of HPV and p53 Mutations in NM Skin Cancer$516,119
R01 · FY2001 · CA
CONTROL OF HIV-1 BY HIV-2 ASSOCIATED IMMUNE RESPONSES$461,415
R01 · FY2001 · AI
EPIDEMIOLOGY &BIOLOGY OF HIV + AND--CERVICAL NEOPLASIA$458,815
R01 · FY2001 · CA
BIOMAKERS DEVELOPMENT LABORATORY$421,288
U01 · FY2001 · CA
CORE--SPECIMEN FACILIGY$0
U54 · FY2001 · CA
CORE--SPECIMEN REPOSITORY AND LABORATORY$0
P50 · FY2001 · CA
CORE--SPECIMEN REPOSITORY AND LABORATORY$0
P50 · FY2001 · CA
CORE--SPECIMEN REPOSITORY AND LABORATORY$0
P50 · FY2001 · CA
CORE--SPECIMEN REPOSITORY AND LABORATORY$0
P50 · FY2001 · CA
EPIDEMIOLOGY OF ANAL HIV-1 INFECTION$595,293
R01 · FY2000 · CA
RANDOMIZED TRIAL ON THE CLINICAL MANAGEMENT OF ASCUS AND$558,818
N01 · FY2000 · CN
CONTROL OF HIV-1 BY HIV-2 ASSOCIATED IMMUNE RESPONSES$518,422
R01 · FY2000 · AI
EPIDEMIOLOGY &BIOLOGY OF HIV + AND--CERVICAL NEOPLASIA$469,884
R01 · FY2000 · CA
BIOMAKERS DEVELOPMENT LABORATORY$409,018
U01 · FY2000 · CA
CORE--SPECIMEN REPOSITORY AND LABORATORY$0
P50 · FY2000 · CA
CORE--SPECIMEN REPOSITORY AND LABORATORY$0
P50 · FY2000 · CA